Health and Fitness Health and Fitness
Wed, October 3, 2012
[ Wed, Oct 03rd 2012 ] - Market Wire
Law Offices of Howard G. Smith Announces Class Ac .. on Lawsuit Against Questcor Pharmaceuticals, Inc.
[ Wed, Oct 03rd 2012 ] - Market Wire
Florida Blue Partners with Healthways to Offer Si .. neakers®;; Fitness Program Through 2015
[ Wed, Oct 03rd 2012 ] - Market Wire
Bovie Medical Announces Initial Orders for J-Plasma™
[ Wed, Oct 03rd 2012 ] - Market Wire
Hologic to Release Fourth Quarter Fiscal 2012 Operating Results on Monday, November 12, 2012
[ Wed, Oct 03rd 2012 ] - Market Wire
MyHumana Mobile App Wins “People&rsquo& .. vorite Smart Phone or Tablet App, 2012 American B
[ Wed, Oct 03rd 2012 ] - Market Wire
CytoDyn Retains Gibraltar Associates for Corporate and Investor Communications
[ Wed, Oct 03rd 2012 ] - Market Wire
Electrochem Offers Expanded Total Power Solutions; Retires Micro Power Brand
[ Wed, Oct 03rd 2012 ] - Market Wire
Phase IIb Data Showed Merck’s Investiga .. bitor MK-3102 Significantly Lowered Blood Sugar i
[ Wed, Oct 03rd 2012 ] - Market Wire
Antares Pharma Announces Pricing of Public Offering of Common Stock
[ Wed, Oct 03rd 2012 ] - Market Wire
Lpath Begins iSONEP Dosing in Nexus Phase 2 Study
[ Wed, Oct 03rd 2012 ] - Market Wire
Verastem to Present at BIO Investor Forum and Participate in Cancer Stem Cell Panel
[ Wed, Oct 03rd 2012 ] - Market Wire
Oxygen Biotherapeutics Signs Cooperative Research .. th U.S. Navy to Investigate the Use of Oxycyte PF
[ Wed, Oct 03rd 2012 ] - Market Wire
Durata Therapeutics to Present at 11th Annual BIO Investor Forum
[ Wed, Oct 03rd 2012 ] - Market Wire
AcelRx Receives Notice of Eligibility for Central .. icines Agency for the Sufentanil NanoTab PCA Syst
[ Wed, Oct 03rd 2012 ] - Market Wire
Aeterna Zentaris Announces Share Consolidation to Regain NASDAQ Compliance
[ Wed, Oct 03rd 2012 ] - Market Wire
Market Influences That Drive Equities Forward - I .. rt on Abbott Laboratories and Glaxosmithkline Plc
[ Wed, Oct 03rd 2012 ] - Market Wire
Sarepta Therapeutics Receives Notice From Departm .. ense for Termination of Ebola Therapeutic Program
[ Wed, Oct 03rd 2012 ] - Market Wire
Sarepta Therapeutics Announces Eteplirsen Meets P .. Novel Dystrophin and Achieves Significant Clinica
[ Wed, Oct 03rd 2012 ] - Market Wire
Lorus Therapeutics to Present at BioContact 2012 in Quebec City
[ Wed, Oct 03rd 2012 ] - Market Wire
Health Management to Present at the Deutsche Bank 20th Annual Leveraged Finance Conference
[ Wed, Oct 03rd 2012 ] - Market Wire
St. Jude Medical's Peripheral Nerve Stimulation S .. dy Confirms Benefit for Chronic Migraine Patients
Tue, October 2, 2012
[ Tue, Oct 02nd 2012 ] - Market Wire
Newman Ferrara LLP Announces A Securities Fraud C .. Been Filed Against Questcor Pharmaceuticals, Inc.
[ Tue, Oct 02nd 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Peregrine Pharmaceuticals, Inc.
[ Tue, Oct 02nd 2012 ] - Market Wire
Albany Medical Center Standardizes to Masimo rainbow SET Pulse CO-Oximetry
[ Tue, Oct 02nd 2012 ] - Market Wire
GreeneStone Supports the Cause of Mental Health with Charitable Foundation
[ Tue, Oct 02nd 2012 ] - Market Wire
Aeterna Zentaris Presented Poster on Oral Prostat .. 120, at International Urology Conference in Japan
[ Tue, Oct 02nd 2012 ] - Market Wire
Milestone Scientific Receives China's SFDA Approval for STA System(R) Computer
[ Tue, Oct 02nd 2012 ] - Market Wire
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum
[ Tue, Oct 02nd 2012 ] - Market Wire
NewLink to Present at 3rd Annual Cancer Immunotherapy Conference
[ Tue, Oct 02nd 2012 ] - Market Wire
LCA-Vision Reports Third Quarter 2012 Procedure Volume
[ Tue, Oct 02nd 2012 ] - Market Wire
Investigational New Drug Application Cleared for Omeros' Lead Compound in PDE10 Program
[ Tue, Oct 02nd 2012 ] - Market Wire
New Data Show no!no! Hair Dominates the Japanese Market for Women’s Hair Removal Devices
[ Tue, Oct 02nd 2012 ] - Market Wire
Antares Pharma Receives Development Milestone Payment
[ Tue, Oct 02nd 2012 ] - Market Wire
Biostar Pharmaceuticals, Inc. To Manufacture And .. ply Xijing Military Hospital With Three New Drugs
[ Tue, Oct 02nd 2012 ] - Market Wire
DARA BioSciences Regains Compliance with NASDAQ $1.00 Minimum Bid Price Rule
[ Tue, Oct 02nd 2012 ] - Market Wire
Studies assess linagliptin treatment in adults wi .. (T2D), as well as add-on to basal insulin therapy
[ Tue, Oct 02nd 2012 ] - Market Wire
Lilly and Boehringer Ingelheim Present Health Out .. for Investigational Novel Basal Insulin Analogue
[ Tue, Oct 02nd 2012 ] - Market Wire
OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference
[ Tue, Oct 02nd 2012 ] - Market Wire
Life Technologies establece un nuevo estndar mundial con el kit GlobalFilera" Express
[ Tue, Oct 02nd 2012 ] - Market Wire
Department of Justice Drops DaVita Inquiry
[ Tue, Oct 02nd 2012 ] - Market Wire
NTRR Formulates Plan to Dramatically Reduce Global Alcohol Addiction
[ Tue, Oct 02nd 2012 ] - Market Wire
Medicure Announces Intention to Seek Expanded Aggrastat Label
Mon, October 1, 2012
[ Mon, Oct 01st 2012 ] - Market Wire
Law Offices of Howard G. Smith Announces Investigation of Questcor Pharmaceuticals, Inc.
[ Mon, Oct 01st 2012 ] - Market Wire
Perrigo Closes Acquisition Of Sergeant's Pet Care Products
[ Mon, Oct 01st 2012 ] - Market Wire
HealthSpring Unveils 2013 Medicare Advantage Plans with More Choices
[ Mon, Oct 01st 2012 ] - Market Wire
Luminex Corporation Participates in Community Initiatives to Save Lives
[ Mon, Oct 01st 2012 ] - Market Wire
Hamilton Medical Center Updates with Masimo Patient Monitoring Technologies
[ Mon, Oct 01st 2012 ] - Market Wire
Tenet Announces Four-Point Plan to Drive Shareholder Value Creation
[ Mon, Oct 01st 2012 ] - Market Wire
Extendicare Announces Exercise of Over-Allotment .. Closes on Lease of Remaining Two Kentucky Centers
[ Mon, Oct 01st 2012 ] - Market Wire
Care Improvement Plus Unveils 2013 Medicare Advantage Plans
[ Mon, Oct 01st 2012 ] - Market Wire
Where We Are Headed -- New Outlook on Hologic, Inc. and St. Jude Medical, Inc.
[ Mon, Oct 01st 2012 ] - Market Wire
XDx Appoints Peter Maag as President and CEO
[ Mon, Oct 01st 2012 ] - Market Wire
Horizon Pharma Announces Completion of Sales Force Expansion
[ Mon, Oct 01st 2012 ] - Market Wire
Implant Sciences Ships Explosives Trace Detectors .. to Protect Petroleum Infrastructure and Transport
[ Mon, Oct 01st 2012 ] - Market Wire
MethylGene Presents Clinical Data on MGCD265 at t .. Society for Medical Oncology (ESMO) 2012 Congress
[ Mon, Oct 01st 2012 ] - Market Wire
FONAR Reports Record Profits From Operations for .. me Doubles From Fiscal 2011;; Revenues Inc
[ Mon, Oct 01st 2012 ] - Market Wire
Bovie Medical to present at the 2012 SeeThruEquit .. p and Microcap Conference on Tuesday, October 2nd
[ Mon, Oct 01st 2012 ] - Market Wire
AVEO and Astellas Announce New Data Presented at .. ing the Safety and Tolerability Profile of Tivoza
[ Mon, Oct 01st 2012 ] - Market Wire
GTx Announces Sale of Fareston®;
[ Mon, Oct 01st 2012 ] - Market Wire
Syneron's elurea" Kicks Off the Break Up. Get Even! Campaign
[ Mon, Oct 01st 2012 ] - Market Wire
Sunshine Heart Announces Conditional Approval of .. E From the FDA for C-Pulse(R) Heart Assist System
[ Mon, Oct 01st 2012 ] - Market Wire
Millennium and Seattle Genetics Highlight Data fr .. imab Vedotin) Trial in Patients with Newly Diagno
[ Mon, Oct 01st 2012 ] - Market Wire
Could Stem Cells Hold the Key to Treating Traumatic Brain Injuries?
Sun, September 30, 2012
[ Sun, Sep 30th 2012 ] - Market Wire
Genomic Health anuncia la presentacin de tres estudios Oncotype DX sobre cncer de mama y colon
[ Sun, Sep 30th 2012 ] - Market Wire
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
[ Sun, Sep 30th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Preliminary D .. H-302 in Combination With Bevacizumab in Patients
[ Sun, Sep 30th 2012 ] - Market Wire
Interim Data for Cabozantinib 40 mg Dose Cohort i .. tant Prostate Cancer Presented at ESMO 2012 Congr
[ Sun, Sep 30th 2012 ] - Market Wire
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Sat, September 29, 2012
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. tment-Naï;ve and Previously-Treated Metas
[ Sat, Sep 29th 2012 ] - Market Wire
Lilly Releases Phase II Results for Monoclonal Antibody Ramucirumab in Lung Cancer
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. Treatment-Naï;;ve and Previously-Treat
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. in Treatment-Naï;;;ve and Previous
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. umab) in Treatment-Naï;;;;ve and
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. limumab) in Treatment-Naï;;;;;
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. (ipilimumab) in Treatment-Naï;;;;
[ Sat, Sep 29th 2012 ] - Market Wire
New Four- and Five-Year Survival Data for YERVOY& .. 59; (ipilimumab) in Treatment-Naï;;;
[ Sat, Sep 29th 2012 ] - Market Wire
ARIAD Presents Initial Clinical Proof-of-Concept .. Non-Small Cell Lung Cancer at ESMO 2012 Congress
[ Sat, Sep 29th 2012 ] - Market Wire
Updated Results from Phase 2b/3 GALAXY Trial Show .. vival from the Addition of Ganetespib to Docetaxe
[ Sat, Sep 29th 2012 ] - Market Wire
Exelixis Announces Data Presentation for GDC-0973 (XL518)
Fri, September 28, 2012
[ Fri, Sep 28th 2012 ] - Market Wire
Unilens Vision Reports FY2012 Operating Results
[ Fri, Sep 28th 2012 ] - Market Wire
Dehaier Medical Signed an Exclusive Distribution .. GCE Group, Europe's Leading Gas-equipment Company
[ Fri, Sep 28th 2012 ] - Market Wire
Mondo Guerra of Project Runway All Stars Hosts In .. ct at One of the Largest Annual HIV Gatherings in
[ Fri, Sep 28th 2012 ] - Market Wire
WellPoint Honored With Two 2012 Brandon Hall Excellence Awards in Sales and Marketing
[ Fri, Sep 28th 2012 ] - Market Wire
IsoRay, Inc. Reports Fiscal Year 2012 Results
[ Fri, Sep 28th 2012 ] - Market Wire
Biotech Industry Look to Benefit From the Introdu .. Technology Small Business Research Incentives Act
[ Fri, Sep 28th 2012 ] - Market Wire
Dynatronics Announces Fourth Quarter and Year-End Results
[ Fri, Sep 28th 2012 ] - Market Wire
Idera Pharmaceuticals to Present at the 3rd Annual Cancer Immunotherapy Conference
[ Fri, Sep 28th 2012 ] - Market Wire
Cytomedix Announces Poster Presentation at Britis .. thetic Plastic Surgeons Annual Scientific Meeting
[ Fri, Sep 28th 2012 ] - Market Wire
A.P. Pharma Resubmits New Drug Application for AP .. the Prevention of Chemotherapy-Induced Nausea an
[ Fri, Sep 28th 2012 ] - Market Wire
Where We Are Headed - New Outlook on Alere Inc. and PerkinElmer, Inc.
[ Fri, Sep 28th 2012 ] - Market Wire
Cytori Awarded Contract Valued up to $106 Million .. arch and Development Authority (BARDA) to Develop
[ Fri, Sep 28th 2012 ] - Market Wire
AVEO and Astellas Announce Submission of New Drug .. or the Treatment of Advanced Renal Cell Carcinoma
[ Fri, Sep 28th 2012 ] - Market Wire
Shareholder Rights Law Firm Johnson & Weaver, LLP .. uestcor Pharmaceuticals Inc. for Securities Fraud
[ Fri, Sep 28th 2012 ] - Market Wire
Swissmedic Invokes Rapid Authorization Procedures for Prochymal Review
[ Fri, Sep 28th 2012 ] - Market Wire
Oncolytics Biotech Inc. Announces the Appointment of Dr. Alan J. Tuchman as Chief Medical Officer
[ Fri, Sep 28th 2012 ] - Market Wire
call for signatures
[ Fri, Sep 28th 2012 ] - Market Wire
EYLEA (aflibercept) Injection Approved for the Tr .. of Wet Age-Related Macular Degeneration in Japan
[ Fri, Sep 28th 2012 ] - Market Wire
Boston Scientific Launches Vercisea" Deep Brain Stimulation System in Europe
[ Fri, Sep 28th 2012 ] - Market Wire
Unprecedented progression-free survival benefit w .. clinically meaningful improvements in life-limit
Thu, September 27, 2012
[ Thu, Sep 27th 2012 ] - Market Wire
30 a.m. Eastern
[ Thu, Sep 27th 2012 ] - Market Wire
Dynamic Energy Alliance to Present at Undiscovered Equities' New York Conference
[ Thu, Sep 27th 2012 ] - Market Wire
Positron To Present At The 1St International Busi .. roviders, Suppliers And Consumers In Moscow, Russ
[ Thu, Sep 27th 2012 ] - Market Wire
Holzer Holzer & Fistel, LLC Announces Investigation into Peregrine Pharmaceuticals, Inc.
[ Thu, Sep 27th 2012 ] - Market Wire
Teva Expands Central Nervous System (CNS) Develop .. n of Huntexil®; Development Program Rights
[ Thu, Sep 27th 2012 ] - Market Wire
Watson Announces Offering of Senior Unsecured Notes
[ Thu, Sep 27th 2012 ] - Market Wire
Oral Arguments in the UCSF Appeal of United State .. Judgment in Favor of InSite Vision Are Scheduled
[ Thu, Sep 27th 2012 ] - Market Wire
BioLineRx Enters into Share Purchase Agreement with Lincoln Park Capital
[ Thu, Sep 27th 2012 ] - Market Wire
Peregrine Pharmaceuticals Announces New Location of Annual Meeting of Stockholders
[ Thu, Sep 27th 2012 ] - Market Wire
A Refreshing Outlook - Consensus Reports on UnitedHealth Group Incorporated and Health Net Inc.
[ Thu, Sep 27th 2012 ] - Market Wire
FDA Clears Life Technologies' OpTmizera" T-Cell Growth Medium for Use in Clinical Trials
[ Thu, Sep 27th 2012 ] - Market Wire
Horizon Pharma to Present at the 11th Annual BIO Investor Forum
[ Thu, Sep 27th 2012 ] - Market Wire
AspenBio Plans to Initiate Pivotal Study in Fourth Quarter
[ Thu, Sep 27th 2012 ] - Market Wire
A Refreshing Outlook - Consensus Reports on Aetna Inc. and Coventry Health Care, Inc.
[ Thu, Sep 27th 2012 ] - Market Wire
Knome Introduces the knoSYS™100; Fi .. Plug-and-Play Human Genome Interpretation System
[ Thu, Sep 27th 2012 ] - Market Wire
BioLineRx Announces Publication of EAGLE Study Re .. Efficacy in Improving Cognitive Function in Schi
[ Thu, Sep 27th 2012 ] - Market Wire
Arnold C. Hanish Elected to Board of Directors of Omeros
[ Thu, Sep 27th 2012 ] - Market Wire
Provectus Expands Protocol for Phase 1 Liver Cancer Study
[ Thu, Sep 27th 2012 ] - Market Wire
Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules
[ Thu, Sep 27th 2012 ] - Market Wire
Syneron anuncia el lanzamiento global de Gentle P .. ual de la European Academy of Dermatology and Ven
Wed, September 26, 2012
[ Wed, Sep 26th 2012 ] - Market Wire
Abattis to Complete Acquisition of FFE Assets &;; Domain Names
[ Wed, Sep 26th 2012 ] - Market Wire
RepliCel's Chief Medical Officer to Present at 21 .. of Dermatology &;; Venereology Congress
[ Wed, Sep 26th 2012 ] - Market Wire
Team Kids and Edwards Lifesciences Host Prominent .. , and Philanthropists for Innovative Thinkers For
[ Wed, Sep 26th 2012 ] - Market Wire
Critical Outcome Technologies Inc. Provides Busin .. s and Scientific Update at Annual General Meeting
[ Wed, Sep 26th 2012 ] - Market Wire
Endo Health Solutions Announces Receipt of Paragraph IV Certifications for OPANA ER
[ Wed, Sep 26th 2012 ] - Market Wire
Where We Are Headed - New Outlook on Forest Labor .. , Inc. and Teva Pharmaceutical Industries Limited
[ Wed, Sep 26th 2012 ] - Market Wire
Critical Alerts For Amgen, Tyco, SanDisk, Lam Research, and Eaton Released By InvestorsObserver
[ Wed, Sep 26th 2012 ] - Market Wire
Janssen and Johnson amp;; Johnson to Prese .. r Canagliflozin in the Treatment of Patients with
[ Wed, Sep 26th 2012 ] - Market Wire
Aethlon Medical Announces the Appointment of Dr. .. adem to its Extracorporeal Science Advisory Board
[ Wed, Sep 26th 2012 ] - Market Wire
Unigene to Target Partnering and Therapeutic Deve .. ng Victory Park Capital Debt Financing and Forbea
[ Wed, Sep 26th 2012 ] - Market Wire
GNS Healthcare and Aetna Using quot;;Big D .. tics to Help Prevent Heart and Metabolic Diseases
[ Wed, Sep 26th 2012 ] - Market Wire
Major Pharmaceutical Stocks Rise After Moody's Upgrades Industry to "Stable"
[ Wed, Sep 26th 2012 ] - Market Wire
Pfizer and GlaxoSmithKline Rise After Moody's Upgrades Pharmaceutical Industry Outlook to "Stable"
[ Wed, Sep 26th 2012 ] - Market Wire
Medicure Announces Development of Novel AGGRASTAT Formulation
[ Wed, Sep 26th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Presentations .. 302 in Pancreatic Cancer and Glioblastoma at ESMO
[ Wed, Sep 26th 2012 ] - Market Wire
BIOGEN IDEC AND SOBI ANNOUNCE POSITIVE TOP-LINE R .. VESTIGATING LONG-LASTING RECOMBINANT FACTOR IX FC
[ Wed, Sep 26th 2012 ] - Market Wire
Uroplasty Announces Coverage of Percutaneous Tibi .. s Urgent PC Neuromodulation System by ConnectiCar
[ Wed, Sep 26th 2012 ] - Market Wire
Frederic Chereau Joins Shire Human Genetic Therapies to Lead Angioedema Franchise
[ Wed, Sep 26th 2012 ] - Market Wire
VentriPoint to Present at the 2012 Aegis Healthcare Conference
[ Wed, Sep 26th 2012 ] - Market Wire
Cutting-edge Robotics Allow Users to Be in 2 Places at Once
Tue, September 25, 2012
[ Tue, Sep 25th 2012 ] - Market Wire
Health Net Announces Appearance at Sanford Bernstein 3rd Annual Healthcare Reform Conference
[ Tue, Sep 25th 2012 ] - Market Wire
Leading Investment Service Examines Cosmetic and Med-Tech Stocks
[ Tue, Sep 25th 2012 ] - Market Wire
Waters Selects Metabolomics Laboratory at Univers .. rth Texas for Center of Innovation Program Honors
[ Tue, Sep 25th 2012 ] - Market Wire
Ergoresearch Ltd/After 12-Month Clinical Study: N .. e Revolutionizes Treatment of Knee Osteoarthritis
[ Tue, Sep 25th 2012 ] - Market Wire
Humana’s Provider Quality Rewards Progr .. illion to Primary Care Physicians Across the U.S.
[ Tue, Sep 25th 2012 ] - Market Wire
Neptune Announces Pricing of US$30 Million Offering of Common Shares
[ Tue, Sep 25th 2012 ] - Market Wire
Aethlon Medical To Present at the Exosomes and Microvesicles 2012 Conference
[ Tue, Sep 25th 2012 ] - Market Wire
International Stem Cell Corp Granted Key Patent for Liver Disease Program
[ Tue, Sep 25th 2012 ] - Market Wire
Neogen reports record first quarter revenue and net income
[ Tue, Sep 25th 2012 ] - Market Wire
Mallinckrodt Joins The Partnership at Drugfree.org to Launch The Medicine Abuse Project
[ Tue, Sep 25th 2012 ] - Market Wire
Extendicare Completes $110 Million Offering of 6. .. nnounces Redemption of Its 7.25% Convertible Debe
[ Tue, Sep 25th 2012 ] - Market Wire
Sunshine Biopharma's Adva-27a Preclinical Researc .. Published in October Issue of ANTICANCER RESEARCH
[ Tue, Sep 25th 2012 ] - Market Wire
AspenBio to Provide Investors with Clinical and Business Update
[ Tue, Sep 25th 2012 ] - Market Wire
Aeterna Zentaris Granted Patent by European Paten .. r AEZS-130 in Growth Hormone Deficiency Diagnosis
[ Tue, Sep 25th 2012 ] - Market Wire
Life Technologies Launches Pervenioa" Lung RS, a .. k Stratification Test for Early Stage Lung Cancer
[ Tue, Sep 25th 2012 ] - Market Wire
Antares Pharma Announces Successful Results from VIBEX MTX Actual Human Use Study
[ Tue, Sep 25th 2012 ] - Market Wire
DARA BioSciences Establishes Vertically Integrate .. for Specialty Oncology Care and Support Products
[ Tue, Sep 25th 2012 ] - Market Wire
GenVec Announces Reduction in Workforce
[ Tue, Sep 25th 2012 ] - Market Wire
OncoSec Establishes Clinical Site for Its Phase I .. static Melanoma Trial at University of Washington
[ Tue, Sep 25th 2012 ] - Market Wire
China to Expand National Health Coverage to Include 20 Major Diseases
Mon, September 24, 2012
[ Mon, Sep 24th 2012 ] - Market Wire
Former Attorney General of Louisiana and Kahn Swi .. Investigate Questcor Pharmaceuticals Inc. Follow
[ Mon, Sep 24th 2012 ] - Market Wire
Electromed, Inc. Reports Fiscal 2012 Fourth-Quarter and Year-End Results
[ Mon, Sep 24th 2012 ] - Market Wire
ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
[ Mon, Sep 24th 2012 ] - Market Wire
pSivida Corp. Reports Fourth Quarter and Fiscal Year 2012 Results
[ Mon, Sep 24th 2012 ] - Market Wire
Boston Therapeutics Announces Filing of S-1 Registration Statement
[ Mon, Sep 24th 2012 ] - Market Wire
Elan Announces Commencement of Tender Offer and Consent Solicitation
[ Mon, Sep 24th 2012 ] - Market Wire
Boston Scientific immette in commercio in Europa .. ettrocatetere impiantabile per la defibrillazione
[ Mon, Sep 24th 2012 ] - Market Wire
Boston Scientific gibt die markteinfhrung einer n .. ibrillationselektrode in Europa und Asien bekannt
[ Mon, Sep 24th 2012 ] - Market Wire
New data from Boehringer Ingelheim and Lilly show .. ength of Diabetes Alliance at EASD Annual Meeting
[ Mon, Sep 24th 2012 ] - Market Wire
Peregrine Pharmaceuticals Announces That It Has D .. in Treatment Group Coding by an Independent Thir
[ Mon, Sep 24th 2012 ] - Market Wire
Savient Pharmaceuticals Names John P. Hamill Chief Financial Officer
[ Mon, Sep 24th 2012 ] - Market Wire
Valeant Pharmaceuticals Acquires Visudyne From QLT
[ Mon, Sep 24th 2012 ] - Market Wire
Nodality, Inc. Appoints Laura Brege as Chief Executive Officer
[ Mon, Sep 24th 2012 ] - Market Wire
Spectrum Pharmaceuticals Provides Update on Belin .. r the Treatment of Relapsed/Refractory Peripheral
[ Mon, Sep 24th 2012 ] - Market Wire
RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program
[ Mon, Sep 24th 2012 ] - Market Wire
Implant Sciences Appoints Former Rapiscan Sales Manager to Accelerate Growth in Air Cargo Market
[ Mon, Sep 24th 2012 ] - Market Wire
Medivation Effects a 2-For-1 Forward Split of Its Common Stock
[ Mon, Sep 24th 2012 ] - Market Wire
Teleflex Receives FDA 510(k) Clearance for ARROW& .. e; Continuous Peripheral Nerve Block Catheter
[ Mon, Sep 24th 2012 ] - Market Wire
BioLineRx Receives Notice of Allowance from USPTO .. n BL-1020, Extending Patent Protection Until 2031
[ Mon, Sep 24th 2012 ] - Market Wire
Sanofi Selects BioClinica’s OnPoint as Enterprise CTMS
Sun, September 23, 2012
[ Sun, Sep 23rd 2012 ] - Market Wire
Linaclotide riceve il parere positivo del CHMP per il trattamento della IBS-C
Fri, September 21, 2012
[ Fri, Sep 21st 2012 ] - Market Wire
LED Medical Diagnostics Inc. Amends Relationship with Henry Schein, Inc.
[ Fri, Sep 21st 2012 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Lead Plain .. tion Lawsuit Against Assisted Living Concepts, In
[ Fri, Sep 21st 2012 ] - Market Wire
Glancy Binkow &;; Goldberg LLP Announce .. The Class Action Lawsuit Against Assisted Living
[ Fri, Sep 21st 2012 ] - Market Wire
Linaclotid erhlt positive Beurteilung des Ausschu .. r Behandlung des Reizdarmsyndroms mit Obstipation
[ Fri, Sep 21st 2012 ] - Market Wire
CORRECTING and REPLACING Forty-One Health Managem .. Measures to Rank on Joint Commission “
[ Fri, Sep 21st 2012 ] - Market Wire
MedCath Announces Filing of Certificate of Dissolution;; Delisting From NASDAQ
[ Fri, Sep 21st 2012 ] - Market Wire
Medicure Announces Proposed Fifteen to One Share Consolidation
[ Fri, Sep 21st 2012 ] - Market Wire
Magellan Health Services Announces Third Quarter 2012 Earnings Conference Call
[ Fri, Sep 21st 2012 ] - Market Wire
Regeneron Announces FDA Approval of EYLEA (aflibe .. ar Edema Following Central Retinal Vein Occlusion
[ Fri, Sep 21st 2012 ] - Market Wire
Regeneron Named World's #1 Biopharmaceutical Employer in Science Magazine Annual Survey
[ Fri, Sep 21st 2012 ] - Market Wire
Mylan Launches First Generic Version of Diovan HCT Tablets
[ Fri, Sep 21st 2012 ] - Market Wire
Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts
[ Fri, Sep 21st 2012 ] - Market Wire
EYLEA (aflibercept) Injection Recommended for App .. of Wet Age-Related Macular Degeneration in Europe
[ Fri, Sep 21st 2012 ] - Market Wire
SunLink Health Systems, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Results
[ Fri, Sep 21st 2012 ] - Market Wire
CHMP Recommends Approval of Cialis for the Treatm .. igns and Symptoms of Benign Prostatic Hyperplasia
[ Fri, Sep 21st 2012 ] - Market Wire
Dehaier Medical Wins Three Year Procurement Agree .. om Major Ukrainian Medical Equipment Manufacturer
[ Fri, Sep 21st 2012 ] - Market Wire
Vanderbilt University and Bristol-Myers Squibb Si .. Develop Novel Treatments for Parkinson’
[ Fri, Sep 21st 2012 ] - Market Wire
Dynatronics Introduces New SolarisPlus Line of Therapy Products
[ Fri, Sep 21st 2012 ] - Market Wire
The Journal Science Again Recognizes Abbott as On .. loyers in the Biotech and Pharmaceutical Industry
[ Fri, Sep 21st 2012 ] - Market Wire
Amedisys Provides Seniors with Tips for September Falls Prevention Month

Idera Pharmaceuticals to Present at the 3rd Annual Cancer Immunotherapy Conference


//health-fitness.news-articles.net/content/2012/ .. -3rd-annual-cancer-immunotherapy-conference.html
Published in Health and Fitness on Friday, September 28th 2012 at 5:30 GMT by Market Wire   Print publication without navigation


CAMBRIDGE, Mass.--([ ])--Idera Pharmaceuticals, (NASDAQ: IDRA) a biotechnology company developing Toll-like receptor candidates for the treatment of autoimmune diseases and for use as vaccine adjuvants, today announced that members of the management team will be presenting at the third annual aCancer Immunotherapy: A Long-Awaited Reality Conferencea at the New York Academy of Medicine in New York City. The presentation will be made on Thursday, October 4, 2012 in Room 21 from 11:00 to 11:15 am.

About Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals applies its proprietary Toll-like receptor (TLR) drug discovery platform to create immunomodulatory drug candidates and has clinical development programs in autoimmune diseases. Additionally, Idera has a collaboration with Merck & Co. for the use of TLR-targeted candidates as vaccine adjuvants. The Company is also advancing its gene-silencing oligonucleotide (GSO) technology for the purpose of inhibiting the expression of disease-promoting genes. For more information, visit [ http://www.iderapharma.com ].


Publication Contributing Sources